Pharma logs 17% growth in Nov; anti-infective therapy drives market demand- QHN
The domestic pharmaceutical market saw its highest growth rate for 2022 in November, at 17.3 per cent, after both volume […]
Q2FY23 preview: Modest revenue growth, Ebitda decline seen in pharma cos- QHN
While domestic market demand is strong, analysts expect higher raw material and freight costs to affect business in US, other […]